Tetracycline for Prostatitis Treatment

Introduction to Prostatitis Treatment

The European Urology Association recommends that tetracycline is not a first-line treatment for prostatitis, with fluoroquinolones being the recommended first-line therapy for chronic bacterial prostatitis and broader-spectrum antibiotics for acute bacterial prostatitis 1, 2

Accurate diagnosis is crucial before initiating treatment, according to the European Urology guidelines 1
The Meares and Stamey 2- or 4-glass test is recommended for diagnosing chronic bacterial prostatitis, as per the European Urology guidelines 1
Microbiological evaluation for atypical pathogens such as Chlamydia trachomatis and Mycoplasma species is necessary in chronic bacterial prostatitis, as stated by the European Urology guidelines 1
Prostatic massage should not be performed in acute bacterial prostatitis due to risk of bacteremia, as advised by the Praxis Medical Insights guidelines 2

For chronic bacterial prostatitis, fluoroquinolones (levofloxacin or ciprofloxacin) are the first-line treatment, given for a minimum of 4 weeks, according to the Praxis Medical Insights guidelines 2
For acute bacterial prostatitis, first-line therapy consists of broad-spectrum antibiotics such as ceftriaxone plus doxycycline for hospitalized patients with severe illness, as recommended by the Praxis Medical Insights guidelines 2

Tetracyclines are contraindicated in pregnancy, nursing women, and children under 8 years of age, as stated by the Ophthalmology guidelines 3
Side effects of tetracyclines include photosensitization, gastrointestinal upset, vaginitis, and rarely, azotemia, according to the Ophthalmology guidelines 3
Tetracyclines have been implicated in cases of pseudotumor cerebri and may interact with other medications, as reported by the Ophthalmology guidelines 3

The European Society of Cardiology recommends monitoring renal function during treatment, especially if using nephrotoxic medications, as low creatinine is not a contraindication for standard antibiotic therapy 4
The European Society of Cardiology suggests avoiding NSAIDs during treatment if possible, as they may affect renal function 4